PATENT CLAIM ANALYSIS

Application Number: 15772893
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "082000"]

Abstract:
The present invention provides compositions and methods for providing controllable local delivery of a conjugate of chloroquine (CQ) and a bisphosphonate to treat diseases characterized by abnormal bone metabolism. In certain embodiments, the invention is used as a treatment for a subject with diseases and disorders characterized by bone loss.

Claim (Index 6):
The compound of  claim 1 , wherein L 2  is alkyl substituted with one to four substituents selected from the group consisting of hydroxyl, alkoxy, alkenyl, cycloalkyl, aryl, heteroaryl, halo, cyano and amino.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.30952
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13646143', '12588882', '14620700', '15621665', '10576228']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8033459971308908
- 35 USC 102 Novelty (BERT): 0.5266588879887055
- Combined Prediction Score: 0.7756772862166723
- Mean Citation Score: 322.2473619999999
- Max Citation Score: 323.93375
- Similarity Product: 230.4047556368261

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test